Questcor Pharmacueticals (QCOR) Tops Q2 EPS by 11c

Questcor Pharmacueticals (NASDAQ: QCOR) reported Q2 EPS of $1.85, $0.11 better than the analyst estimate of $1.74. Revenue for the quarter came in at $278.8 million versus the consensus estimate of $261.02 million.

For earnings history and earnings-related data on Questcor Pharmacueticals (QCOR) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• EquipmentShare.com Inc. (EQPT) Reports Q2 EPS of $0.18; Offers Guidance
• Gaxos.ai Inc. (GXAI) Reports Q2 EPS of $0.02